Takeda Pharmaceutical
TAK
#469
Rank
HK$411.24 B
Marketcap
HK$130.16
Share price
-0.06%
Change (1 day)
21.63%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): HK$26.00 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.86 Billion. , an increase over its 2024 earnings that were of HK$17.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 HK$26.04 B49.03%
2024 HK$17.47 B-2.41%
2023 HK$17.90 B-28.14%
2022 HK$24.91 B-40.9%
2021 HK$42.16 B78.24%
2020 HK$23.65 B246.1%
2019 HK$6.83 B-48.79%
2018 HK$13.34 B-23.64%
2017 HK$17.47 B21.7%
2016 HK$14.36 B-253.01%
2015 -HK$9.39 Billion-159.65%
2014 HK$15.73 B13%
2013 HK$13.92 B2.46%
2012 HK$13.58 B-57.05%
2011 HK$31.63 B-10.49%
2010 HK$35.34 B-3.99%
2009 HK$36.81 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.44 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.60 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$82.94 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.16 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$59.97 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$102.99 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.40 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.2 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.83 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India